Sarah J Verity
Biographic Data
| ID | 8265809 |
|---|---|
| NAME | Sarah J Verity |
| GIVEN NAMES | Sarah J |
| FAMILY NAME | Verity |
| SIGNATURE | VERITY S J |
| AFFILIATIONS | Newcastle upon Tyne Hospitals NHS Foundation Trust |
| ORCID | 0000-0001-9111-780X |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship
Methylphenidate has an established role in the management of attention-deficit hyperactivity disorder and attentional deficit secondary to brain injury. Increasingly, methylphenidate is considered for the attentional deficit in paediatric brain tumour survivors. A small number of studies have explored the benefit of methylphenidate in this population; however, studies are of short duration and do not address the impact of medium to long-term use …
I Feel Happy Again”
Survivors of PBT reported favorable views as to the subjective benefit of methylphenidate on post-treatment impairment of HRQoL. This medication may offer the potential for restoration of a sense of 'normality' of function following cancer treatment in this clinical population
No prominent works on this page.
I Feel Happy Again”
Survivors of PBT reported favorable views as to the subjective benefit of methylphenidate on post-treatment impairment of HRQoL. This medication may offer the potential for restoration of a sense of 'normality' of function following cancer treatment in this clinical population
Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship
Methylphenidate has an established role in the management of attention-deficit hyperactivity disorder and attentional deficit secondary to brain injury. Increasingly, methylphenidate is considered for the attentional deficit in paediatric brain tumour survivors. A small number of studies have explored the benefit of methylphenidate in this population; however, studies are of short duration and do not address the impact of medium to long-term use …
Attention Deficit Hyperactivity Disorder (2 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Methylphenidate (2 works) · Population (2 works) · Psychiatry (2 works) · Psychology (2 works) · Cancer-related cognitive impairment studies (1 work)